Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Balchem (BCPC) Common Equity (2016 - 2025)

Balchem (BCPC) has disclosed Common Equity for 16 consecutive years, with $1.3 billion as the latest value for Q2 2025.

  • On a quarterly basis, Common Equity rose 13.98% to $1.3 billion in Q2 2025 year-over-year; TTM through Jun 2025 was $1.3 billion, a 13.98% increase, with the full-year FY2024 number at $1.1 billion, up 9.1% from a year prior.
  • Common Equity was $1.3 billion for Q2 2025 at Balchem, up from $1.2 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $1.3 billion in Q2 2025 to a low of $849.5 million in Q1 2021.
  • A 5-year average of $1.0 billion and a median of $990.2 million in 2023 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: rose 0.77% in 2022, then increased 14.82% in 2024.
  • Balchem's Common Equity stood at $877.0 million in 2021, then rose by 6.99% to $938.3 million in 2022, then grew by 12.33% to $1.1 billion in 2023, then grew by 9.1% to $1.1 billion in 2024, then increased by 10.26% to $1.3 billion in 2025.
  • Per Business Quant, the three most recent readings for BCPC's Common Equity are $1.3 billion (Q2 2025), $1.2 billion (Q1 2025), and $1.1 billion (Q4 2024).